Novo Nordisk
Novo Nordisk Pharmatech A/S was established in 1949. It is the leading worldwide supplier of recombinant insulin, which is sourced directly from Novo Nordisk, the world’s largest producer. Its recombinant insulin is a key component in serum free growth media for mammalian cells and approved by regulatory bodies worldwide, including FDA and EMA. The company’s products are manufactured to cGMP standards, and have distinguished itself for:
- Global regulatory compliance
- Consistent high quality
- Extensive regulatory documentation
- Continuous availability
- Secure global supply chain
- High levels of service and support
